DSM Q1 2016 results
(Thomson Reuters ONE) -
Highlights
* DSM reports a strong first quarter
* Group net sales up at ?1,913 million, with 2% organic growth
* Group EBITDA up 19% to ?296 million
* Nutrition: 6% organic sales growth, EBITDA up 15%
* Materials: EBITDA up 10%, supported by low input costs
* Group ROCE: improved to 9.8% (Q1 2015: 6.8%) driven by EBIT growth
* Outlook maintained
Key figures and indicators (continuing operations)
-------------------------------------------------------------------
in ? million Q1 2016 Q1 2015 % Change Volume Price/mix FX Other
-------------------------------------------------------------------
Sales 1,913 1,886 1% 5% -3% -2% 1%
Nutrition 1,250 1,199 4% 7% -1% -4% 2%
Materials 600 632 -5% 1% -6% 0%
EBITDA 296 248 19%
Nutrition 225 195 15%
Materials 95 86 10%
ROCE (%) 9.8% 6.8%
-------------------------------------------------------------------
CEO statement
Feike Sijbesma, CEO/Chairman of the DSM Managing Board, commented: "We are
pleased to report that we delivered a strong first quarter in terms of growth,
profitability and returns, with all businesses seeing the effects of our
improvement programs.
Both Animal and Human Nutrition delivered above-market volume growth, with Human
Nutrition showing a marked improvement, albeit against a relatively weak
comparable quarter in 2015. Our efforts resulted in EBITDA growth and an
improved margin in Nutrition. Materials remained robust, helped in part by the
shift towards higher added-value products in the portfolio.
In addition, low input prices continued to support margins during Q1 2016
despite softer volumes in some segments, although we expect this support to
diminish somewhat going forward.
While the macro-economic environment remains uncertain, we are confident that we
will deliver in line with our medium-term goals. This will be supported by
innovation, our growth initiatives and underpinned by our group-wide cost and
productivity improvement programs."
Outlook 2016
DSM aims to deliver increased full-year EBITDA and ROCE in line with the targets
set out in its Strategy 2018: Driving Profitable Growth.
Note for the editors: for the full text of the press release, see enclosed pdf
or click here>
Contact Information
Investor Relations Dave Huizing
t. +31 (0) 45 578 28 64
e. investor.relations(at)dsm.com
Media Relations Stephen Hufton
t. +31 (0) 45 578 7029
e. media.contacts(at)dsm.com
Additional Information
Today DSM will hold a conference call for media from 08:00 to 08:30 and a
conference call for investors and analysts from 09:00 to 10:00. Details on how
to access these calls can be found on the DSM website, www.dsm.com.
Press Release-pdf:
http://hugin.info/130663/R/2006519/741384.pdf
Q1 2016 Presentation to investors-pdf:
http://hugin.info/130663/R/2006519/741518.pdf
Q1 2016 Key figures-pdf:
http://hugin.info/130663/R/2006519/741517.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via GlobeNewswire
[HUG#2006519]
Unternehmensinformation / Kurzprofil:
Datum: 26.04.2016 - 07:00 Uhr
Sprache: Deutsch
News-ID 466292
Anzahl Zeichen: 4214
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 200 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DSM Q1 2016 results"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
